Aquestive Therapeutics (AQST) EBT Margin Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aquestive Therapeutics | 583.72 Mn | 583.72 Mn | 9.80 Mn | -3,001.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,001.00 |
| Mar 31, 2026 | 20,719.00 |
| Dec 31, 2025 | 24,798.00 |
| Sep 30, 2025 | -3,562.00 |
| Jun 30, 2025 | -12,178.00 |
| Mar 31, 2025 | -15,653.00 |
| Dec 31, 2024 | -8,318.00 |
| Sep 30, 2024 | -6,826.00 |
| Jun 30, 2024 | 2,794.00 |
| Mar 31, 2024 | -17,889.00 |
| Dec 31, 2023 | 5,498.00 |
| Sep 30, 2023 | 9,263.00 |
| Jun 30, 2023 | 16,218.00 |
| Mar 31, 2023 | 18,021.00 |
| Dec 31, 2022 | 14,565.00 |
| Sep 30, 2022 | 18.00 |
| Jun 30, 2022 | 41,458.00 |
| Mar 31, 2022 | 7,566.00 |
| Dec 31, 2021 | -668.00 |
| Sep 30, 2021 | 9,734.00 |